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Summary
Background:  Subchondral  bone  cyst  (SBC)  formation  is  often  identiﬁed  in  patients  with
osteoarthritis.  Furthermore,  several  studies  have  shown  that  expression  of  matrix  metallo-
proteinases  (MMPs)  is  elevated  in  patients  with  OA.
Objectives:  The  aim  of  our  study  is  to  correlate  the  presence  of  SBCs  and  MMP-1  expression
with the  osteochondral  alterations  during  OA  progression.
Methods:  We  studied  the  cartilage  and  subchondral  bone  of  15  patients  who  had  undergone
total knee  or  hip  replacement  due  to  primary  OA.  As  controls,  we  used  the  femoral  heads  of
three patients  without  macroscopic  OA  changes.  We  evaluated  three  specimens  per  patient.
Results:  Specimens  were  divided  in  four  groups  based  on  the  Mankin  histological  severity  score.
Using immunohistochemistry,  we  noted  SBCs  at  the  site  of  greatest  disease  severity.  Speciﬁcally,
these were  present  more  frequently  in  group  III  (Mankin  score:  6—7)  and  IV  (Mankin:  ≥  8),  com-
pared with  group  I  (Mankin:  1—3)  and  II  (Mankin:  4—5).  Mild  OA  stages  (Mankin:  1—6)  were
characterized  by  degeneration  and  thinning  of  the  cartilage,  followed  by  increased  osteoblast
and osteoclast  activity  of  the  subjacent  bone  and  the  subsequent  appearance  of  SBCs.  Simul-
taneously,  we  observed  expression  of  MMP-1  in  groups  I and  II  in  the  cartilage  and  III  and  IV  in
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both  the  cartilage  and  the  subchondral  bone.  Moreover,  osteoblast-like  cells  in  the  lining  of  the
SBCs showed  an  increased  expression  of  MMP-1  in  stages  III  and  IV.
Conclusion:  Our  study  provides  immunohistological  evidence  that  SBCs  accumulate  in  advanced
OA and  contain  activated  cells,  which  express  MMP-1,  suggesting  that  they  may  thus  participate
in the  osteochondral  changes  of  OA.
Level  of  evidence:  Level  III;  prospective  comparative  study.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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steoarthritis  (OA)  is  the  major  cause  of  disability  in  the
dult  population.  Although  in  the  past  it  was  considered  as
 primary  disorder  of  articular  cartilage,  it  is  now  gener-
lly  considered  as  a  disease  of  the  whole  joint,  including
he  calciﬁed  cartilage,  subchondral  cortical  and  trabecular
one,  joint  capsular  tissues  and  the  synovium  [1].  Not  only
he  structural  support,  but  also  the  biological  cross-talk
etween  bone  and  cartilage,  make  subchondral  bone  and
artilage  become  a  closely  functional  unit  that  cannot  be
eparated  [2].  A characteristic  of  bone  adaptation  associ-
ted  with  OA  is  the  presence  of  subchondral  bone  cysts  (SBC)
3]  that  are  present  in  about  50%  of  subjects  with  knee  OA
4,5].
Subchondral  bone  cysts  (SBCs),  ‘‘pseudocysts’’  or
‘geodes’’  [6—8],  were  ﬁrst  identiﬁed  by  Ondrouch  [9]  and
andells  [10]  in  the  load-bearing  regions  of  the  femur,
atella,  and  shoulder  of  arthritic  patients,  although  the
xact  cause  is  not  well  known  [8].  Currently,  there  are
wo  main  theories:  the  ‘‘Bone  Contusion  Theory’’  where
ony  microcontusions  below  the  joint  surface,  associated
ith  increased  intra-articular  pressure  lead  to  extension  of
ynovial  ﬂuid  into  the  subchondral  bone  through  tiny  gaps
n  the  articular  surface,  and  the  ‘‘Synovial  Breach  The-
ry’’  where  a  breach  in  the  subchondral  plate  caused  by
 diminished  local  cartilage  leads  to  a  rapid  inﬂammation
esponse  and  the  proliferation  of  myxomatous  tissue  within
he  bone  marrow  [6,8,9,11].  Subchondral  cystic  lesions
ppear  as  well-delimited  areas  of  ﬂuid  signal  on  magnetic
esonance  imaging  (MRI),  corresponding  to  radiolucencies
ncompassed  with  sclerotic  margins  on  standard  radiographs
12,13].  They  are  currently  gaining  increasing  attention  for
heir  potential  etiologic  role  in  the  development  and  pro-
ression  of  OA.  Moreover,  their  presence  is  associated  with
ncreased  cartilage  loss  and  risk  of  knee  joint  replacement
14].
The  matrix  metalloproteinases  (MMPs)  are  a  family  of
3  proteolytic  enzymes  that  share  several  structural  and
unctional  characteristics  with  different  substrate  speciﬁci-
ies.  MMPs  degrade  proteins  of  the  extracellular  matrix  and
hey  have  been  considered  the  main  enzymes  responsible
or  degradation  of  collagens  in  OA  cartilage  [15].  MMP-1
s  an  interstitial  collagenase  that  is  capable  of  degrading
nterstitial  collagens  (types  I,  II  and  III)  and  is  thought  to  be
 multifunctional  molecule  with  important  roles  in  diverse
hysiologic  processes  maintaining  osteochondral  integrity
16,17].In this  study,  we  correlated  SBCs  presence  and  MMP-1
xpression  in  different  OA  stages  by  using  histological  and
mmunohistological  measurements,  in  order:  to  shed  light  on
c
c
pBCs  role  during  the  progression  of  OA  and  to  explore  their
orrelation  with  MMP-1  expression  at  the  whole  cartilage-
ubchondral  bone  functional  unit.
Our  hypothesis  was  that  SBCs  might  be  associated  with
ncreased  MMP-1  expression.
atients and methods
verall,  15  patients  aged  60—89  years  diagnosed  with  idio-
athic  OA  of  the  hip  or  of  the  knee  in  accordance  with  the
riteria  of  the  American  College  of  Rheumatology  [18,19]
ere  included  and  compared  to  three  controls  aged  68—83
ears  (Table  1).  Exclusion  criteria  were  as  follows:  secondary
rthritis,  haemochromatosis,  hip  fractures,  inﬂammatory  or
utoimmune  diseases,  malignancies,  intra-articular  admin-
stration  of  steroids.  Eight  patients  suffered  of  knee  OA  and
even  of  hip  OA.  OA  severity  was  estimated  based  on  pain,
unctionality,  and  clinical  data  using  the  Harris  score  for
ip  OA  [20]  and  the  index  of  severity  (ISK)  for  knee  OA
21]. Radiographically,  assessment  of  OA  was  based  on  the
hlback  classiﬁcation  for  the  knee  OA  [22]  and  the  Kellgren
 Lawrence  for  hip  OA  [23].  The  same  orthopaedic  surgeon
pecialized  in  OA  evaluated  all  X-rays.  Controls  consisted
f  three  femoral  heads  [24—27],  which  were  harvested  in
atients  undergoing  hip  hemiarthroplasty  following  fracture
f  the  femoral  neck.  All  control  patients  had  no  known  his-
ory  of  bone  or  joint  disease  and  their  cartilage  was  free  of
A  lesions  (grade  0),  according  to  the  Collins  scale  modiﬁed
y  Muehleman  et  al.  [28].
Ethical  approval  and  informed  consent  were  received,
ccording  to  the  1964  Helsinki  Declaration.
istology and immunohistochemistry
e  evaluated  three  specimens  per  patient,  and  per  control.
istology
he  specimens  were  ﬁxed  in  10%  buffered  formalin  for
4—36  h,  decalciﬁed  in  neutral  ethylene-diamine-tetra-
cetic  acid  (EDTA)  for  6—8  weeks  at  room  temperature,
nd  embedded  in  parafﬁn  blocks.  Three-micrometer  thick
istological  sections  were  obtained  and  stained  with  Haema-
oxylin/Eosin.  The  quantitative  histological  evaluation  of
he  specimens  was  based  on  a  modiﬁed  form  of  the  Mankin
cale  [29,30].  Normal  cartilage  was  graded  as  0,  while  the
cale  went  up  proportionally  to  the  severity  of  the  OA
hanges.  In  addition,  the  status  of  chondrocytes  and  the  sub-
hondral  area  were  similarly  graded.  The  total  score  of  all
arameters  characterized  the  severity  of  the  OA  changes  in
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Table  1  Characteristics  of  the  study  population.
Characteristics  OA  Patients  (n  =  15)  Controls  (n  =  03)
Sexa 14  females,  1  male  2  females,  1  male
Mean age  (years)b 72.4  ±  8.29  (Min:  63,  Max:  89)  72.3  ±  6.66  (Min:  65,  Max:  78)
Mean height  (cm)b 164.4  ±  5.355  (Min:  156,  Max:  173)  172.67  ±  2.52  (Min:  170,  Max:  175)
Mean weight  (kg)b 85.5  ±  15.16  (Min:  65,  Max:  110)  77.10  ±  7.94  (Min:  68,  Max:  83)
a Expressed as number of individuals.
b Expressed as mean ± standard deviation.
every  histological  section.  Four  groups  of  OA  were  formed:
Group  I  was  constituted  of  sections  with  Mankin  score  1—3,
group  II  with  Mankin  score  4—5  and  group  III  and  IV  with
Mankin  score  6—7  and  greater  or  equal  to  8,  respectively.
The  sums  of  scores  of  all  sections  in  each  group  were  sta-
tistically  analysed  and  compared  with  immunohistochemical
staining  for  MMP-1  in  the  same  sections.
Immunohistochemistry
The  slices  were  deparafﬁnised  in  xylene  and  degraded
alcohols,  immersed  in  distilled  water.  The  endogenous  per-
oxidase  was  blocked  with  3%  H2O2 for  30  min  in  a  dark
chamber  at  room  temperature.  Sections  were  then  washed
in  distilled  water  and  three  times  with  TBS,  incubated  for
1  hour  at  room  temperature  with  anti-MMP  1/8  (H-300)
(Santa  Cruz  sc-30069)  diluted  1:50  in  antibody  diluents
(DAKO  REAL  S2022),  incubated  for  45  min  at  room  tem-
perature  with  peroxidase-labelled  anti-mouse/rabbit  IgG
(En-vision  Kit,  DAKO  Detection  System,  Peroxidase/DAB+,
Rabbit/Mouse  K5007),  washed  three  times  with  TBS,  and
stained  for  10  minutes  in  a  dark  chamber  at  room  tem-
perature  with  3-amino-9-ethylcarbazole/H2O2,  washed  in
distilled  and  counterstained  with  haematoxylin.
Statistical analysis
Kruskal-Wallis  test  was  used  for  comparing  the  histological
and  immunohistochemical  evaluation  results  of  the  sections
between  the  groups  of  patients  with  OA  results.  Differences
were  considered  signiﬁcant  when  P-values  were  inferior  to
0.05.
Results
Subchondral  bone  cysts  and  Mankin  score  in  OA
Histological  ﬁndings  were  identical  for  all  the  non-
communicating  cysts,  which  contained  necrotic  bone
fragments  with  dead  denuclearized  cells.  The  cavities  were
surrounded  by  a  layer  of  ﬁbrous  connective  tissue  contain-
ing  adipocytes  and  osteoblasts.  Overall,  the  frequency  of
SBCs  was  signiﬁcantly  greater  in  groups  III  and  IV  (Fig.  1A).
Speciﬁcally,  their  frequency  in  patients  with  knee  OA  was
higher  in  the  group  III  (Fig.  1B).  Their  frequency  in  patients
with  hip  OA  (Fig.  1C)  was  remarkably  increased  in  group  IV
(P  =  0.028).
Figure  1  A.  Overall  results  from  the  immunohistoche-
mical  analysis  processed  statistically.  B.  Results  from  the
immunohistochemical  analysis  of  the  knee  OA  patients.
C. Immunohistochemical  ﬁndings  in  patients  with  Hip  OA.
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(igure  2  Cartilage  and  subchondral  bone  without  OA  changes
n a  control  negative  for  MMP-1.
xpression  of  MMP-1  in  OA  tissuesartilage  and  subchondral  bone  matrix  and  cells,  as  well  as
he  cystic  lesions  of  OA  patients  were  stained  positively  for
MP-1,  while  it  was  undetectable  in  controls  (Fig.  2).  MMP-1
xpression  was  observed  in  the  sections  of  the  second,  third
D
T
e
igure  3  A.  Cartilage  matrix  (black  arrows)  with  positive  expressio
ytes in  aggregations  (red  arrows).  B.  Fibrocartilage  (black  arrows)  a
ith a  Mankin  score  of  7.  C.  A  large  number  of  subchondral  cysts  (bl
 patient  with  a  Mankin  score  of  6.  D.  MMP-1  expression  in  cartilag
red arrows),  from  a  slice  with  a  Mankin  score  of  7.A.  Kaspiris  et  al.
nd  fourth  group  and  its  staining  rose  signiﬁcantly  with  the
everity  of  OA  changes.  Additionally,  the  frequency  of  MMP-
 expression  in  the  cartilage  and  in  the  subchondral  bone
as  increased  in  groups  III  and  IV  compared  with  the  groups
 and  II  in  both  patients  with  knee  (P  =  0.03  and  P  =  0.002,
espectively)  and  hip  OA  (P  =  0.0019  and  P  =  0.0014,  respec-
ively).
MMP-1  was  detected  in  the  matrix  during  the  aggregation
f  chondrocytes  (Fig.  3A)  and  in  the  ﬁbrocartilage  (Figs.  3B
nd  C),  pannus  (Fig.  3D)  or  ﬁssures  (Fig.  4A).  In  the  subchon-
ral  bone,  MMP-1  was  detected  around  the  osteoblast-like
ells  (Fig.  4B)  and  in  the  bone-lining  cells  (Fig.  4B).  The
resence  of  osteoblast-like  cells  was  accompanied  by  the
imultaneous  presence  of  osteoclasts,  mainly  in  group  III.
owever,  expression  of  MMP-1  in  the  osteoclasts  around  the
ysts  was  not  observed  (Fig.  4C).  In  group  IV  there  was  an
ncreased  number  of  apoptotic  osteocytes  positive  for  MMP-1
Fig.  4D).
The  wall  osteoblasts  of  SBCs  in  groups  III  and  IV  also
xpressed  MMP-1  (Figs.  5  and  6A  and  B),  whereas  MMP-1
xpression  was  not  detectable  in  groups  I and  II  (Fig.  6C).iscussion
o  the  best  of  our  knowledge,  this  is  the  ﬁrst  study  that
xamines  the  relationship  between  the  presence  of  SBC  and
n  for  MMP-1  in  a  patient  with  a  Mankin  score  of  5  and  chondro-
nd  cartilage  matrix  (red  arrows)  positive  for  MMP-1  in  a  patient
ack  arrows)  with  overlying  ﬁbrocartilage  tissue  (red  arrows)  in
e  with  pannus  (black  arrows)  and  chondrocytes  in  aggregation
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Figure  4  A.  Presence  of  subchondral  cysts  presenting  osteoblastic  expression  of  MMP-1  in  overlying  cartilage  with  crevices  (black
arrows). We  note  ﬁbrous  tissue  (red  arrows)  in  the  cyst  wall.  From  a  slice  with  a  Mankin  score  of  7.  B.  Intense  MMP-1  expression
in the  walls  of  subchondral  cysts  and  the  subchondral  bone  by  osteoblast-like  cells  (black  arrows)  and  lining  cells  (red  arrows)  in  a
slice with  a  Mankin  score  of  8.  C.  Subchondral  bone  cyst  showing  mild  expression  of  MMP-1,  from  mural  osteoblast-like  cells  (black
arrows). Adjacent,  we  observed  MMP-1  expression  by  subchondral  osteoblast-like  cells  and  an  aggregation  of  multinuclear  cells
.  D.  Expression  of  MMP-1  in  ﬁbrocartilage  tissue,  in  osteoblast-like
ound  a  SBC  (Mankin  score  8).(osteoclasts, red  arrows)  from  a  slice  with  a  Mankin  score  of  5
cells (black  arrows)  and  in  apoptotic  osteocytes  (red  arrows)  ar
MMP-1  expression.  Despite  the  small  number  of  patients
in  the  control  group  the  results  reached  signiﬁcance.  It  is
important  to  note  that  our  observations  mostly  derived  from
female  patients,  reﬂecting  an  epidemiological  proportion  of
OA  in  our  region.
The  frequency  of  SBC  was  related  to  the  severity  of
the  degenerative  changes  and  they  were  found  to  develop
at  the  site  of  greatest  disease  severity,  which  is  con-
sistent  with  other  studies  in  humans  [31]  and  in  animal
models,  such  as  the  rat  anterior  cruciate  ligament  transec-
tion  model  [3].  It  also  looks  in  agreement  with  the  theory
of  Ondrouch,  according  to  which  SBCs  appearance  is  pre-
ceded  by  joint  narrowing  that  would  induce  subchondral
bone  micro-fracture  in  response  to  repeated  overloading.
SBCs  were  found  to  coexist  with  increased  cell  number
of  osteoblasts  and  osteoclasts.  Additionally,  defects  ﬁlled
by  ﬁbrocartilage  were  observed  around  the  cysts  (Fig.  4A),
which  were  also  surrounded  by  large  numbers  of  apop-
totic  osteocytes.  This  suggests  incomplete  healing  following
repeated  microtrauma,  leading  to  further  deterioration  and
ﬁnally  to  focal  osteonecrosis  [3].
Another  important  ﬁnding  is  the  concurrent  secretion  of
MMP-1  in  the  subchondral  bone-lining  cells  in  Mankin  stages
6  or  more  (Fig.  6D).  Although  the  heterogeneity  of  their
osteoblastic  phenotype  has  been  well  established,  bone-
lining  cells  constitute  a  subpopulation  of  the  osteoblastic
family,  which  responds  to  abnormal  mechanical  loading.
Before  osteoclastic  attachment  and  resorption,  bone-lining
Figure  5  We  note  MMP-1  expression  in  osteocytes  (black
arrows),  in  cartilage  tissue  with  pannus  (red  arrows)  and  mild
expression  in  areas  of  cystic  processes  in  the  cartilage  and  sub-
chondral  bone  (Mankin  6).
528  A.  Kaspiris  et  al.
Figure  6  A.  Bone  cyst  with  lining  osteoblast-like  cells  that  express  MMP-1  (black  arrows).  In  an  adjacent  area  we  note  bone-lining
cells (red  arrows)  with  mild  expression  of  MMP-1  (Mankin  score  7).  B.  MMP-1  expression  by  osteoblast-like  cells  (black  arrows)  in  the
lining of  a  SBC  from  a  slice  with  a  Mankin  score  of  5.  C.  We  note  osteoblast-like  cells  in  the  lining  of  a  SBC  with  low  expression  of
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n a  patient  with  Mankin  score  9.
ells  digest  non-mineralized  collagen  protruding  from  the
one  surface,  action  that  would  be  activated  by  MMPs  [32].
The  SBC  osteoblast-like  cells  showed  an  increased  expres-
ion  of  MMP-1  in  Mankin  stages  greater  than  6,  which  would
ccount  for  degradation  of  non-mineralized  collagen  type
,  exposing  binding  sites  on  the  surface  of  the  bone.  This
as  been  shown  to  be  a  prerequisite  for  osteoclast  stimula-
ion  and  attachment  to  the  bone  [33—36].  Our  data  are  in
greement  with  the  study  of  Sasaki  et  al.  showing  that  stro-
al  lining  cells  and  osteoblasts  would  express  MMP-1,  upon
echanical  stimulation,  thus  preparing  recruitment  sites  for
steoclasts  [37].  Furthermore,  the  presence  study  showed
he  coexistence  of  SBCs  with  apoptotic  osteocytes  express-
ng  MMP-1,  in  late  stages  of  OA.  The  relationship  of  MMP-1
ith  cell  apoptosis  has  been  suggested  by  recent  reports
roviding  evidence  for  the  role  of  MMP-1  in  targeting  non-
atrix  substrates,  such  as  cell  bound  cytokines,  enzymes
nd  cell  surface  receptors  [38].
These  ﬁndings  have  clinical  signiﬁcance  and  show  that
BCs,  as  well  as  MMP-1,  may  be  directly  involved  in  the
rogress  of  the  disease.  It  has  been  reported  that  the  pres-
nce  of  SBCs  increases  the  risk  of  joint  replacement  [14]
nd  revision  arthroplasty  [39].  In  fact,  increased  expres-
ion  of  MMP-1  is  implicated  in  the  aseptic  loosening  of  joint
eplacement  implants  [40].eoblast-  like  (black  arrows)  and  bone-lining  cells  (red  arrows)
onclusion
n  conclusion,  MMP-1  expression  by  osteoblasts,  the  lin-
ng  cells  of  the  subchondral  bone  and  SBCs  in  advanced
A  stages,  may  contribute  to  the  pathological  tissue
emodelling  and  the  osteochondral  changes  in  OA.  Hence,
argeting  MMP-1  may  provide  an  important  therapeutic
lternative  for  OA  that  affect  not  only  the  cartilage  but  the
ubchondral  bone,  as  well.
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